As of 2025-07-14, the EV/EBITDA ratio of Jiangxi Fushine Pharmaceutical Co Ltd (300497.SZ) is -28.55. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 300497.SZ's latest enterprise value is 6,891.61 mil CNY. 300497.SZ's TTM EBITDA according to its financial statements is -241.39 mil CNY. Dividing these 2 quantities gives us the above 300497.SZ EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
Range | Selected | |
Trailing P/E multiples | 15.3x - 19.8x | 16.4x |
Forward P/E multiples | 10.1x - 11.3x | 11.1x |
Fair Price | (9.27) - 1.17 | (4.32) |
Upside | -192.8% - -88.3% | -143.3% |
Date | EV/EBITDA |
2025-07-04 | -26.70 |
2025-07-03 | -26.95 |
2025-07-02 | -26.48 |
2025-07-01 | -26.64 |
2025-06-30 | -26.27 |
2025-06-27 | -25.75 |
2025-06-26 | -25.66 |
2025-06-25 | -26.04 |
2025-06-24 | -26.32 |
2025-06-23 | -25.84 |
2025-06-20 | -25.59 |
2025-06-19 | -25.63 |
2025-06-18 | -26.43 |
2025-06-17 | -26.70 |
2025-06-16 | -26.98 |
2025-06-13 | -26.84 |
2025-06-12 | -27.34 |
2025-06-11 | -27.32 |
2025-06-10 | -27.62 |
2025-06-09 | -27.43 |
2025-06-06 | -26.91 |
2025-06-05 | -26.98 |
2025-06-04 | -27.25 |
2025-06-03 | -27.59 |
2025-05-30 | -27.52 |
2025-05-29 | -28.18 |
2025-05-28 | -26.34 |
2025-05-27 | -26.68 |
2025-05-26 | -25.22 |
2025-05-23 | -25.72 |
2025-05-22 | -25.13 |
2025-05-21 | -25.38 |
2025-05-20 | -25.70 |
2025-05-19 | -25.34 |
2025-05-16 | -25.45 |
2025-05-15 | -25.11 |
2025-05-14 | -24.86 |
2025-05-13 | -25.09 |
2025-05-12 | -25.13 |
2025-05-09 | -25.22 |
2025-05-08 | -25.68 |
2025-05-07 | -25.56 |
2025-05-06 | -25.70 |
2025-04-30 | -25.02 |
2025-04-29 | -25.04 |
2025-04-28 | -25.45 |
2025-04-25 | -24.88 |
2025-04-24 | -24.70 |
2025-04-23 | -24.70 |
2025-04-22 | -24.93 |